Please assess the completion status of the following clinical trial:

Trial Title: Study on B-blockers to Prevent Decompensation of Cirrhosis With HTPortal

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Between 18 and 80 years old.~* With liver cirrhosis diagnosed by previous biopsy or by clinical criteria, and analytical image.~* No esophageal varices (or with small varices without red signs) in a recent videogastroscophy (\<3 months before randomization).~* Absence of ascites demonstrated by a recent ultrasound (\<3 months before the randomization).~* informed consent~Exclusion Criteria:~* previous decompensation of liver cirrhosis associated with portal hypertension.~* GPVH \<10 mmHg.~* Portal axis thrombosis affecting the portal trunk or main hepatic branches, or the splenic or mesenteric vein.~* Hepatocellular carcinoma demonstrated by two imaging tests.~* Bilirubin\> 3 mg / dl (or\> 50 micromol / l), platelets \<30 x10E9/lo Quick \<30%.~* Presence of renal insufficiency (serum creatinine\> 2 mg / dl or\> 200 micromol / l).~* Any comorbidity involving a therapeutic limitation and / or a prognosis of life \<12 months.~* Absolute contraindication to treatment with β-blockers (severe bronchospasm, stenosis aortic A-V block, intermittent claudication, severe psychosis, bronchial asthma)~* Hypersensitivity to β-blockers.~* Pregnancy or lactation.~* To receive anticoagulant treatment.~* Past treatment with nitrated or β-blockers in the two weeks prior inclusion.~* Cirrhosis C virus active antiviral therapy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Propranolol (Type: EXPERIMENTAL): None
- carvedilol (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).